BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 8509157)

  • 1. Clinical relevance of antibodies to Ro/SS-A and La/SS-B in subacute cutaneous lupus erythematosus and related conditions.
    Zappi E; Sontheimer R
    Immunol Invest; 1993 Apr; 22(3):189-203. PubMed ID: 8509157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of antibodies to Ro/SS-A and La/SS-B in subacute cutaneous lupus erythematosus and related conditions.
    Zappi E; Sontheimer R
    Clin Dermatol; 1992; 10(4):431-41. PubMed ID: 1303808
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-Ro(SS-A) HLA-DR3-positive women: the interrelationship between some ANA negative, SS, SCLE, and NLE mothers and SS/LE overlap female patients.
    Provost TT; Watson R
    J Invest Dermatol; 1993 Jan; 100(1):14S-20S. PubMed ID: 8423383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A major autoepitope is present on the amino terminus of a human SS-A/Ro polypeptide.
    Lieu TS; Newkirk MM; Arnett FC; Lee LA; Deng JS; Capra JD; Sontheimer RD
    J Autoimmun; 1989 Aug; 2(4):367-74. PubMed ID: 2477002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ro/SS-A and the pathogenic significance of its antibodies.
    McCauliffe DP; Lux FA; Lieu TS; Sanz I; Hanke J; Newkirk MM; Siciliano MJ; Sontheimer RD; Capra JD
    J Autoimmun; 1989 Aug; 2(4):375-81. PubMed ID: 2477003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic importance of anti-Ro autoantibodies].
    Dörner T; Hiepe F
    Z Arztl Fortbild (Jena); 1992 Mar; 86(5):203-10. PubMed ID: 1585672
    [No Abstract]   [Full Text] [Related]  

  • 7. Polymorphisms of HLA class II genes and autoimmune responses to Ro/SS-A-La/SS-B among Japanese subjects.
    Miyagawa S; Shinohara K; Nakajima M; Kidoguchi K; Fujita T; Fukumoto T; Yoshioka A; Dohi K; Shirai T
    Arthritis Rheum; 1998 May; 41(5):927-34. PubMed ID: 9588746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Ro(SS-A) antibody positive Sjögren's/lupus erythematosus overlap syndrome.
    Provost TT; Watson R; Simmons-O'Brien E
    Lupus; 1997; 6(2):105-11. PubMed ID: 9061658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can B cell epitopes of 60 kDa Ro distinguish systemic lupus erythematosus from Sjögren's syndrome?
    Scofield AN; Kurien BT; Gordon TP; Scofield RH
    Lupus; 2001; 10(8):547-53. PubMed ID: 11530996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Ro in Sjögren's syndrome and systemic lupus erythematosus.
    Harley JB; Scofield RH; Reichlin M
    Rheum Dis Clin North Am; 1992 May; 18(2):337-58. PubMed ID: 1626073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies and their target antigens in Sjögren's syndrome.
    Meilof JF; Smeenk RJ
    Neth J Med; 1992 Apr; 40(3-4):140-7. PubMed ID: 1603204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunogenetic relationship between anti-Ro(SS-A)/La(SS-B) antibody positive Sjögren's/lupus erythematosus overlap syndrome and the neonatal lupus syndrome.
    Alexander EL; McNicholl J; Watson RM; Bias W; Reichlin M; Provost TT
    J Invest Dermatol; 1989 Dec; 93(6):751-6. PubMed ID: 2584740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody responses to the "native" 52-kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjogren's syndrome.
    Buyon JP; Slade SG; Reveille JD; Hamel JC; Chan EK
    J Immunol; 1994 Apr; 152(7):3675-84. PubMed ID: 7511655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of detection of SS-A/Ro autoantibody in screening immunofluorescence tests for autoantibodies to nuclear antigens.
    Bylund DJ; Nakamura RM
    J Clin Lab Anal; 1991; 5(3):212-8. PubMed ID: 2061745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical significance of Ro (SS-A) and La (SS-B) antibodies in lupus erythematosus.
    Provost TT
    Semin Dermatol; 1988 Jun; 7(2):130-9. PubMed ID: 3153434
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoimmune sera react with multiple epitopes on recombinant 52 and 60 kDa Ro(SSA) proteins.
    McCauliffe DP; Yin H; Wang LX; Lucas L
    J Rheumatol; 1994 Jun; 21(6):1073-80. PubMed ID: 7523671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ro/SS-A and La/SS-B antibody level variation in patients with Sjögren's syndrome and systemic lupus erythematosus.
    Wahren M; Tengnér P; Gunnarsson I; Lundberg I; Hedfors E; Ringertz NR; Pettersson I
    J Autoimmun; 1998 Feb; 11(1):29-38. PubMed ID: 9480721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 52 000 MW Ro/SS-A autoantigen in Sjögren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures.
    Rhodes DA; Ihrke G; Reinicke AT; Malcherek G; Towey M; Isenberg DA; Trowsdale J
    Immunology; 2002 Jun; 106(2):246-56. PubMed ID: 12047754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant 52 kDa Ro(SSA) ELISA detects autoantibodies in Sjögren's syndrome sera that go undetected by conventional serologic assays.
    McCauliffe DP; Wang L; Satoh M; Reeves WH; Small D
    J Rheumatol; 1997 May; 24(5):860-6. PubMed ID: 9150073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic lupus erythematosus: clinical expression and anti-Ro/SS--a response in patients with and without lesions of subacute cutaneous lupus erythematosus.
    López-Longo FJ; Monteagudo I; González CM; Grau R; Carreño L
    Lupus; 1997; 6(1):32-9. PubMed ID: 9116716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.